BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:     

Global Tuberculosis Strategies

Global Tuberculosis Strategies


The importance, danger and costs of tuberculosis in the 21st century cannot be understated or underestimated. Though nearly extinct in the 20th century, Over 1.6 billion people worldwide suffer from tuberculosis, and it is now presenting a major crisis in public health circles.

In addition to the basic pathology and complications of tuberculosis, there are primarily three focal points for the development of strategy in this area: potential market, epidemiology (tuberculosis patient trends) and technology.

Kalorama Information's Global Tuberculosis Strategies, authored by Kalorama Information analyst Kenneth G. Krul, PhD, covers these points in detail and presents the most authoritative look at the global tuberculosis threat, strategies to combat tuberuclosis, and the market opportunities that can be created in tuberculosis treatement. As part of its coverage, the report includes:

Extensive Tuberculosis Etiology necessary to underatnd this unique disease.

Epidemiologic Statistics including 30 Tables of Incidence, Prevalance and Mortality Statistics by Region and by Type of Tuberculosis.

Theoretical Market Sizes for Testing and Treatment by Region and by Type of Tuberculosis (MDR and non-MDR).

Complete overview of Tuberculosis Screening Procedures.

Review of Products used for treatment of Tuberculosis.

A Glossary of Important Terms.

A truly global round-up, the report focuses in detail on the following regions:

Africa

The Americas

Eastern Mediterranean

Europe

Southeast Asia

Western Pacific

Jun 1, 2007

250 Pages

PDF Format
Table of Contents
Price: $3,995.00 / GBP1,997.50



Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.

Back to top